344 related articles for article (PubMed ID: 32158593)
21. Contribution of Complementarity-Determining Region 3 of the T-Cell Receptor Vδ2 Chain to the Recognition of Aminobisphosphonates by Human γδ T-Cells.
Nishimura H; Hirokawa M; Fujishima N; Fujishima M; Miura I; Sawada K
Int J Hematol; 2004 May; 79(4):369-76. PubMed ID: 15218968
[TBL] [Abstract][Full Text] [Related]
22. A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DR.
Deseke M; Rampoldi F; Sandrock I; Borst E; Böning H; Ssebyatika GL; Jürgens C; Plückebaum N; Beck M; Hassan A; Tan L; Demera A; Janssen A; Steinberger P; Koenecke C; Viejo-Borbolla A; Messerle M; Krey T; Prinz I
J Exp Med; 2022 Sep; 219(9):. PubMed ID: 35852466
[TBL] [Abstract][Full Text] [Related]
23. γδ T cell frequencies are altered in HIV positive pregnant South African women and are associated with preterm birth.
Akoto C; Chan CYS; Ravi K; Zhang W; Vatish M; Norris SA; Hemelaar J
PLoS One; 2020; 15(6):e0235162. PubMed ID: 32584913
[TBL] [Abstract][Full Text] [Related]
24. Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance.
Davey MS; Willcox CR; Joyce SP; Ladell K; Kasatskaya SA; McLaren JE; Hunter S; Salim M; Mohammed F; Price DA; Chudakov DM; Willcox BE
Nat Commun; 2017 Mar; 8():14760. PubMed ID: 28248310
[TBL] [Abstract][Full Text] [Related]
25. Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias.
Pistoia V; Tumino N; Vacca P; Veneziani I; Moretta A; Locatelli F; Moretta L
Front Immunol; 2018; 9():984. PubMed ID: 29867961
[TBL] [Abstract][Full Text] [Related]
26. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
Liu Y; Zhang C
Cells; 2020 May; 9(5):. PubMed ID: 32413966
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals.
Ryan PL; Sumaria N; Holland CJ; Bradford CM; Izotova N; Grandjean CL; Jawad AS; Bergmeier LA; Pennington DJ
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14378-14383. PubMed ID: 27911793
[TBL] [Abstract][Full Text] [Related]
28. Long-term use of interferon-β in multiple sclerosis increases Vδ1
Maimaitijiang G; Watanabe M; Shinoda K; Isobe N; Nakamura Y; Masaki K; Matsushita T; Yoshikai Y; Kira JI
J Neuroinflammation; 2019 Sep; 16(1):179. PubMed ID: 31519178
[TBL] [Abstract][Full Text] [Related]
29. Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme.
Lee M; Park C; Woo J; Kim J; Kho I; Nam DH; Park WY; Kim YS; Kong DS; Lee HW; Kim TJ
Front Immunol; 2019; 10():555. PubMed ID: 30967876
[TBL] [Abstract][Full Text] [Related]
30. The distinct MHC-unrestricted immunobiology of innate-like and adaptive-like human γδ T cell subsets-Nature's CAR-T cells.
Willcox CR; Mohammed F; Willcox BE
Immunol Rev; 2020 Nov; 298(1):25-46. PubMed ID: 33084045
[TBL] [Abstract][Full Text] [Related]
31. Increased effector γδ T cells with enhanced cytokine production are associated with inflammatory abnormalities in severe hand, foot, and mouth disease.
Shen Y; Pan Z; Zhang L; Xue W; Peng M; Hu P; Xu H; Chen M
Int Immunopharmacol; 2019 Aug; 73():172-180. PubMed ID: 31100712
[TBL] [Abstract][Full Text] [Related]
32. Gammadelta T lymphocytes producing IFNgamma and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation.
Poggi A; Catellani S; Musso A; Zocchi MR
Curr Med Chem; 2009; 16(35):4743-9. PubMed ID: 19903136
[TBL] [Abstract][Full Text] [Related]
33. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
Rong L; Li K; Li R; Liu HM; Sun R; Liu XY
World J Gastroenterol; 2016 Apr; 22(13):3573-80. PubMed ID: 27053849
[TBL] [Abstract][Full Text] [Related]
34. Association of Decreased Percentage of Vδ2
Maimaitijiang G; Shinoda K; Nakamura Y; Masaki K; Matsushita T; Isobe N; Yamasaki R; Yoshikai Y; Kira JI
Front Immunol; 2018; 9():748. PubMed ID: 29692781
[TBL] [Abstract][Full Text] [Related]
35. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
Kress E; Hedges JF; Jutila MA
Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401
[TBL] [Abstract][Full Text] [Related]
36. Characterization of γδ T cells in patients with non-small cell lung cancer.
Bao Y; Guo L; Mo J
Oncol Lett; 2017 Jul; 14(1):1133-1140. PubMed ID: 28693285
[TBL] [Abstract][Full Text] [Related]
37. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
[TBL] [Abstract][Full Text] [Related]
38. Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches.
Sanz M; Mann BT; Chitrakar A; Soriano-Sarabia N
Cells; 2022 Nov; 11(22):. PubMed ID: 36429001
[TBL] [Abstract][Full Text] [Related]
39. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.
Knight A; Mackinnon S; Lowdell MW
Cytotherapy; 2012 Oct; 14(9):1110-8. PubMed ID: 22800570
[TBL] [Abstract][Full Text] [Related]
40. γδ T Lymphocytes: An Effector Cell in Autoimmunity and Infection.
Shiromizu CM; Jancic CC
Front Immunol; 2018; 9():2389. PubMed ID: 30386339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
